The latest price target for Organogenesis Hldgs (NASDAQ:ORGO) was reported by Lake Street on June 28, 2024. The analyst firm set a price target for $5.00 expecting ORGO to rise to within 12 months (a possible 77.30% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Organogenesis Hldgs (NASDAQ:ORGO) was provided by Lake Street, and Organogenesis Hldgs initiated their buy rating.

The last upgrade for Organogenesis Holdings Inc happened on May 24, 2023 when BTIG raised their price target to $10. BTIG previously had a neutral for Organogenesis Holdings Inc.

The last downgrade for Organogenesis Holdings Inc happened on November 10, 2022 when BTIG changed their price target from N/A to N/A for Organogenesis Holdings Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organogenesis Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organogenesis Hldgs was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.

While ratings are subjective and will change, the latest Organogenesis Hldgs (ORGO) rating was a initiated with a price target of $0.00 to $5.00. The current price Organogenesis Hldgs (ORGO) is trading at is $2.82, which is within the analyst’s predicted range.